Economic benefits of global equitable access to COVID-19 vaccines

Published on December 3, 2020

Global equitable access to COVID-19 vaccines estimated to generate economic benefits of at least US$ 153 billion in 2020–21, and US$ 466 billion by 2025, in 10 major economies, according to new report by the Eurasia Group.  WHO